Bill Ackman And Valeant Settle Allergan Insider Trading Lawsuit For $290 Million |
| January 04, 2018 | January 2018 Bond Updates |
|
Hedge funder Bill Ackman and Valeant Pharmaceuticals will pay $290 million to settle claims from shareholders in Allergan they engaged in insider trading when pressing a takeover of the botox-maker in 2014. The settlement means Valeant likely cost Pershing $4 billion. |
| View more at: https://www.forbes.com/sites/antoinegara/2017/12/30/bill-ackman-and-valeant-settle-allergan-insider-trading-lawsuit-for-290-million/ |
| Related News |
|